$16.66
-0.76-4.36%
Pre-Market: Nov 14, 6:37 PM EDT
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Comments
Loading...
ProShares UltraShort Nasdaq Biotechnology
BISNASDAQ
Sector
Unknown
Region
US
AUM
3.07M
Fund Score
ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Quotes, Forecast and News Summary
ProShares UltraShort Nasdaq Biotechnology (NASDAQ: BIS) stock price, news, charts, stock research, profile.
| Open | - |
| High | - |
| 52 Wk High | $24.61 |
| AUM | 3.07M |
| Dividend | $0.61 |
| Ex-Div Date | Jun 26, 2024 |
| Volume | - |
| Market Cap | - |
| Mgmt Fee | 0.75% |
| P/E Ratio | - |
| Prev. Close | $17.42 |
| Low | - |
| 52 Wk Low | $14.05 |
| Shares Out | 171.10K |
| Yield | 3.92% |
| Div. Freq | U |
| Avg. Volume Daily | 8.96K |
| Beta | -1.15 |
| Avg. Expense Ratio | 0.95% |
| P/B Ratio | - |
Recent News
FAQ
Q
How do I buy ProShares UltraShort Nasdaq Biotechnology (BIS) stock?
A
You can purchase shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) through any online brokerage.
Q
Who are ProShares UltraShort Nasdaq Biotechnology (BIS) competitors?
A
There are no as such competitors for ProShares UltraShort Nasdaq Biotechnology.
Q
What is the forecast, or price target, for ProShares UltraShort Nasdaq Biotechnology (BIS) stock?
A
There is no analysis for ProShares UltraShort Nasdaq Biotechnology to provide a consensus price target.
Q
What is the current price for ProShares UltraShort Nasdaq Biotechnology (BIS)?
A
The stock price for ProShares UltraShort Nasdaq Biotechnology (NASDAQ: BIS) is $17.42 last updated November 20, 2024 at 4:15 PM EST.
Q
Does ProShares UltraShort Nasdaq Biotechnology (BIS) pay a dividend?
A
A quarterly cash dividend of 0.15 per share of Class A Common Stock. The quarterly cash dividend was payable on October 2, 2024 to stockholders of record on September 25, 2024.
Q
When is ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) reporting earnings?
A
ProShares UltraShort Nasdaq Biotechnology does not have any upcoming earnings scheduled.
Q
Is ProShares UltraShort Nasdaq Biotechnology (BIS) going to split?
A
There is no upcoming split for ProShares UltraShort Nasdaq Biotechnology.
| Open | - |
| High | - |
| 52 Wk High | $24.61 |
| AUM | 3.07M |
| Dividend | $0.61 |
| Ex-Div Date | Jun 26, 2024 |
| Volume | - |
| Market Cap | - |
| Mgmt Fee | 0.75% |
| P/E Ratio | - |
| Prev. Close | $17.42 |
| Low | - |
| 52 Wk Low | $14.05 |
| Shares Out | 171.10K |
| Yield | 3.92% |
| Div. Freq | U |
| Avg. Volume Daily | 8.96K |
| Beta | -1.15 |
| Avg. Expense Ratio | 0.95% |
| P/B Ratio | - |
ETF Details
| Sector | Unknown |
| Category | - |
| Investment Style | Trading-Inverse Equity |
| Fund Inception | Apr 6, 2010 |
| Managers | Tarak Dave Michael Neches |
| Definition | - |
Investment Policy
The Fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The Index is constructed and maintained by Nasdaq Inc. (the Index Provider). The Index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by the Index Provider, including minimum market capitalization and liquidity requirements.
Popular Channels
Tools & Features
Partners & Contributors
About Benzinga
© 2024 Benzinga | All Rights Reserved